📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Variantyx

1.1 - Company Overview

Variantyx Logo

Variantyx

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of molecular diagnostics specializing in advanced genetic testing: PCR-free whole genome sequencing for uniform coverage and detection of clinically relevant variants; IriSight tests for SNVs, indels, structural, repeat expansions, mitochondrial variants; Genomic Intelligence analytical software; OncoAlly tumor profiling using WGS, WES and RNA; and ClaudIA for Genomics producing actionable reports for cancer treatment management.

Products and services

  • OncoAlly: Multi-omic testing service for tumor profiling and treatment optimization, integrating whole genome sequencing, whole exome sequencing, and RNA analysis to characterize tumors across DNA and RNA dimensions
  • Whole Genome Sequencing (WGS) Platform: PCR-free platform delivering uniform patient DNA coverage, enabling detection of all major clinically relevant variant types
  • IriSight: Portfolio-based test suite that detects a wide range of genetic variants, including SNVs, indels, structural variants, repeat expansions, and mitochondrial variants across patient samples

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Variantyx

NXT-Dx Logo

NXT-Dx

HQ: Belgium Website
  • Description: Provider of epigenetics services from a private company led by an experienced team combining skills in epigenetics, transcriptomics, proteomics, and bioinformatics research.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NXT-Dx company profile →
Gentris Logo

Gentris

HQ: United States Website
  • Description: Provider of global pharmacogenomic testing and biorepository services, helping pharmaceutical companies and clinical research organizations integrate pharmacogenomics into drug development to deliver safer, more effective compounds to market more quickly.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Gentris company profile →
Neogen Logo

Neogen

HQ: United States Website
  • Description: Provider of food and animal safety products, developing, manufacturing and marketing a diverse line dedicated to food and animal safety.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Neogen company profile →
WestBred Logo

WestBred

HQ: United States Website
  • Description: Provider of highest yield potential wheat seed designed for regional conditions, including certified single-variety seed containing no other crops, foreign material, or certain seed-borne diseases; Clearfield Plus production system for grass and broadleaf weed control using Beyond herbicide; grower resources such as optimal seeding rate guidance; intellectual property protection for varieties; and the National Wheat Yield Contest.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full WestBred company profile →
Amyris Logo

Amyris

HQ: United States Website
  • Description: Provider of biotech chemical products made via advanced sugarcane-derived fermentation. Portfolio includes Neossance Squalane for cosmetics and skincare moisturization and barrier repair; Artemisinic Acid used in antimalarial treatments; Biosilica from sugarcane ashes for cosmetics; Neossance Hemisqualane as a plant-based silicone alternative; Biofene renewable specialty chemical building block; RealSweet Reb M zero-calorie sweetener.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Amyris company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Variantyx

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Variantyx

2.2 - Growth funds investing in similar companies to Variantyx

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Variantyx

4.2 - Public trading comparable groups for Variantyx

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Variantyx

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Variantyx

What does Variantyx do?

Variantyx is a provider of molecular diagnostics specializing in advanced genetic testing: PCR-free whole genome sequencing for uniform coverage and detection of clinically relevant variants; IriSight tests for SNVs, indels, structural, repeat expansions, mitochondrial variants; Genomic Intelligence analytical software; OncoAlly tumor profiling using WGS, WES and RNA; and ClaudIA for Genomics producing actionable reports for cancer treatment management.

Who are Variantyx's competitors?

Variantyx's competitors and similar companies include NXT-Dx, Gentris, Neogen, WestBred, and Amyris.

Where is Variantyx headquartered?

Variantyx is headquartered in United States.

How many employees does Variantyx have?

Variantyx has 1,000 employees 🔒.

When was Variantyx founded?

Variantyx was founded in 2010 🔒.

What sector and industry vertical is Variantyx in?

Variantyx is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Variantyx

Who are the top strategic acquirers in Variantyx's sector and industry

Top strategic M&A buyers and acquirers in Variantyx's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Variantyx?

Top strategic M&A buyers groups and sectors for Variantyx include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Variantyx's sector and industry vertical

Which are the top PE firms investing in Variantyx's sector and industry vertical?

Top PE firms investing in Variantyx's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Variantyx's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Variantyx's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Variantyx's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Variantyx include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Variantyx's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Variantyx?

The key public trading comparables and valuation benchmarks for Variantyx include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Variantyx for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Variantyx with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Variantyx's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Variantyx with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Variantyx's' sector and industry vertical?

Access recent funding rounds and capital raises in Variantyx's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Variantyx